About: CTEP

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5, binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR5 antagonists such as MPEP and fenobam.

Property Value
dbo:abstract
  • CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5, binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR5 antagonists such as MPEP and fenobam. (en)
dbo:casNumber
  • 871362-31-1
dbo:fdaUniiCode
  • E3BWG5775S
dbo:pubchem
  • 11646823
dbo:thumbnail
dbo:wikiPageID
  • 34541581 (xsd:integer)
dbo:wikiPageLength
  • 2683 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1122879818 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 19 (xsd:integer)
dbp:casNumber
  • 871362 (xsd:integer)
dbp:chemspiderid
  • 9821562 (xsd:integer)
dbp:cl
  • 1 (xsd:integer)
dbp:f
  • 3 (xsd:integer)
dbp:h
  • 13 (xsd:integer)
dbp:iupacName
  • 2 (xsd:integer)
dbp:iupharLigand
  • 6409 (xsd:integer)
dbp:n
  • 3 (xsd:integer)
dbp:o
  • 1 (xsd:integer)
dbp:pubchem
  • 11646823 (xsd:integer)
dbp:smiles
  • Clc2ccC#Cc1ncn-cccc3OCF (en)
  • FCOc3ccccc3 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • GOHCTCOGYKAJLZ-UHFFFAOYSA-N (en)
dbp:unii
  • E3BWG5775S (en)
dbp:width
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5, binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. In animal studies it was found to have a high oral bioavailability and a long duration of action, lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR5 antagonists such as MPEP and fenobam. (en)
rdfs:label
  • CTEP (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License